Background: Bipolar affective disorder (BPAD) and schizophrenia (SCZ) are common conditions. Their causes are unknown, but they include a substantial genetic component. Previously, we described significant linkage of BPAD to a chromosome 4p locus within a large pedigree (F22). Others subsequently have found evidence for linkage of BPAD and SCZ to this region.
F amily, twin, and adoption studies have shown that both BPAD (MIM 125480) and SCZ (MIM 181500) have a significant genetic component but that inheritance patterns are complex. Family and molecular studies also indicate that some genetic risk factors may contribute to predisposition to both SCZ and affective disorders, and there can be overlap in their clinical presentation (Berrettini 2000; Blackwood et al 1996; Maier et al 2002; Potash et al 2001) . Previously, we described a large Scottish pedigree (F22) in which many family members experience symptoms of BPAD or recurrent major depressive disorder (unipolar depression [MIM 125480]) . A whole genome scan of F22 found significant linkage of major affective disorder to chromosome 4p (maximum logarithm of the odds [LOD] score ϭ 4.09; Blackwood et al 1996) . Further support for this result comes from variance component analysis of the same data, which found significant evidence for a quantitative trait locus in the region (LOD of 3.7; Visscher et al 1999) .
Subsequent to our report, a number of other groups also have found evidence for linkage of both BPAD and SCZ to the F22 linkage region. These reports include linkage in a Welsh family with SCZ and schizoaffective disorder (F50, LOD ϭ 1.97; Asherson et al 1998), linkage in two Danish BPAD families (LOD ϭ 2.00; Ewald et al 1998), linkage to major mental illness (including both SCZ and BPAD) in a large family from the United States (1 of 22 studied; F48, LOD ϭ 3.24; Detera-Wadleigh et al 1999) , linkage to BPAD with psychosis and suicidal behavior in a bipolar pedigree sample from the United States (LOD ϭ 1.84; Cheng et al 2006) , increased sharing in Welsh SCZ sib-pairs (LOD ϭ 1.73; Williams et al 1999) , a nonparametric LOD score of 2.2 in Arab Israeli families with SCZ and schizoaffective disorder (Lerer et al 2003) , and excess haplotype sharing (best p value, p ϭ .00007) in families from the Faroe Islands with BPAD and SCZ (Als et al 2004) . A patient with schizophrenia and a balanced translocation t(4;13) (p16.1;q21.31) also highlights this region of chromosome 4p (Itokawa et al 2004) . Finally, we have recently described preliminary evidence for association in GPR78, an orphan G-protein coupled receptor, in females with BPAD and SCZ (Underwood et al 2006) . GPR78 maps to the F22 linkage region, but this finding has not yet been replicated, and we have no evidence for segregation of functional variants with the disorder in F22. Therefore, here we describe a systematic approach to narrowing the linkage region on chromosome 4p. Toward this objective, here we present an updated genetic analysis of two Scottish families with BPAD and recurrent major depressive disorder (F22, F59; Blackwood et al 1996) ; F50, a Welsh family with SCZ and schizoaffective disorder (Asherson et al 1998) ; and F48, a large U.S. family of Ashkenazi Jewish origin with BPAD, SCZ, recurrent major depressive disorder, and related conditions (Detera-Wadleigh et al 1999) . In addition, we include clinical description, linkage and haplotype analysis of new cases of illness within F22, which strengthens our original finding (Blackwood et al 1996) . Previously, F22, F59, and F50 had been subjected to low-resolution haplotype analysis with publicly available microsatellite markers at ϳ5 to 15 cM intervals (Asherson et al 1998; Blackwood et al 1996) . F48 previously had been subject to a whole genome scan for linkage (DeteraWadleigh et al 1999) . This analysis found a chromosome 4p marker with a significant LOD score (3.24) and two markers from 4p14 -p16 with elevated allele sharing, but this result had not been followed up by haplotype analysis. Our aim was to define the chromosome 4p regions linked to illness in the above four families at high resolution. We identified, mapped, and genotyped new polymorphic markers from the region, allowing us to define all recombination breakpoints accurately. High-resolution haplotype analysis is essential for accurate definition of a linked region, because any misspecification of the model used in linkage analysis will mean that the peak LOD score does not necessarily correspond to the most likely position of the susceptibility gene.
The definition of the linked haplotypes allowed us to define regions of overlap between them. These linkage results in the four families may reflect independent mutations at the same locus (allelic heterogeneity) or a common ancient origin (founder mutation). I f there is allelic heterogeneity then it should be possible to identify independent polymorphisms at a single locus, as was the case in Crohn's disease (MIM 605966; Hugot et al 2001) . If there is a founder mutation common to more than one family, then this will be flanked by a region of haplotype sharing that varies in extent between the families but includes a functional variant that is common to all cases. The presence of shared alleles on linked chromosomes from families with chromosome 8p-linked schizophrenia was used to identify a region of the NRG1 locus that was subsequently found to show association with SCZ in the Icelandic and Scottish populations (Stefansson et al 2002) . We have developed a novel method to compare the extent of allele sharing in positional candidate genes between the four chromosomes that segregate with illness with that observed between the control chromosomes from the four families. This greatly improves the definition of the region most likely to contain a susceptibility gene for BPAD and, in view of the varied phenotypes seen in these families, possibly for other disorders, including schizoaffective disorder and SCZ.
Methods and Materials
This study was approved by the Multicentre Research Ethics Committee for Scotland, and appropriate informed consent was obtained from the human subjects.
Reevaluation of F22 Family Members
Since the original study, through continued contact with the family, we have identified five new cases in F22. All were interviewed using Schedule for Affective Disorders and SchizophreniaLifetime Version (SADS-L) (Blackwood et al 1996) , and a consensus diagnosis using DSM-IV criteria was reached by two experienced psychiatrists (WJM and DHRB). The offspring in one family were removed from the analysis because major psychiatric illness was detected in first-degree relatives of the married in parent. This was not a fully systematic follow up, as some family members could not be interviewed.
Identification of New Microsatellite Markers
Initially, a minimum overlapping set of clones was chosen across the region to be investigated and subjected to partial digestion and subcloning, as described in the PAC subcloning section. Clones from the resultant library were hybridized with (CA) 15 and (GT) 15 oligos. The inserts of positive subclones were sequenced. Latterly, the sequences of BAC clones from the contig were retrieved from the EMBL database. All sequences were processed by Sputnik (http://www.abajian.com/sputnik/) and RepeatMasker (http://repeatmasker.genome.washington.edu/ cgi-bin/RM2_req.pl). The Sputnik source code was altered (specifically, the ERROR_MATCH_POINTS symbolic constant was decreased from Ϫ6 to Ϫ100) to ensure that only perfect simple tandem-repeat arrays, that is, those made up of identical repeat units, were detected. Perfect simple tandem-repeat arrays longer than the following thresholds (12 repeat units for dinucleotide repeats, 7 for trinucleotides, 6 for tetranucleotides, and 5 for pentanucleotides) were identified. For each of these microsatellites, the 200-bp flanking sequence was excised from the relevant BAC sequence and used in primer design (Genbank accession numbers BV677285 to BV677322).
P1 Derived Artificial Chromosome (PAC) Subcloning
Clones were partially cleaved with Sau3AI under conditions that generate fragments ranging in size from 1.5 to .5 kb. Fragments were resolved on a 1% agarose gel (Invitrogen, Paisley, United Kingdom) run in 1ϫ tris, acetic acid, EDTA (TAE). After electrophoresis, fragments of approximately .8 kb were excised, the gel slice was spun in a Spinex column (Corning BV, Schiphol-Riik, The Netherlands), and the DNA was concentrated by ethanol precipitation. The recovered fragments were ligated to pBluescript SK ϩ/Ϫ (Stratagene Europe, Amsterdam, Zuiduost, The Netherlands) vector that had been cut with BamHI, gel purified, and treated with heat killed (HK) phosphatase (Cambio, Cambridge, United Kingdom). Ligated DNA was electrotransformed into XL1-Blue cells (Stratagene), and recombinants were identified by plating approximately 400 colonies on a 12 ϫ 8 cm L-agar plate containing ampicillin (80 g/mL), isopropyl-1-thio-␤-D-galactopyranoside (.1 mM) and 5-bromo-4-chloro-3-indolyl-␤-Dgalactopyranoside (.1 mM). White (recombinant) colonies were picked, with a Flexys FLX11001 robot (PBA Technologies Cambridge, United Kingdom) fitted with a six-needle picking head, into five 384-well microtiter plates containing L-broth, ampicillin (80 g/mL), and 7% glycerol.
Production of Filters
Clones from the above plates were gridded with a Flexys FLX11001 robot (PBA Technologies) onto Hybond Nϩ nylon membrane (GE Healthcare, Little Chalfont, Bucks, United Kingdom). The gridded filters were processed essentially as described in Cole et al (1996) , with the exception that the spheroplasting stage was omitted.
Oligo Hybridization
Fifty nanograms of oligonucleotide was end-labeled with 30 Ci of ␥-32 P adenosine triphosphate (Ͼ5000 Ci/mmol, Amersham) by using 10 U of polynucleotide kinase (Roche, Lewes, East Sussex, United Kingdom) at 37°C for 40 min. Unlabeled oligonucleotides were removed by passing the reaction mixture through a NAP5 column (Amersham Biosciences, Chalfont St. Giles, Bucks, United Kingdom), according to manufacturer's instructions. The eluate was hybridized to filters of gridded clones overnight, at 72°C, in a hybridization mixture containing 5ϫ sodium saline citrate (SSC), .1% sodium pyrophosphate, .5% sodium dodecyl sulfate (SDS), 5ϫ Denhardt's, and 100 g/mL of sonicated salmon sperm. Filters were washed in 6ϫ SSC-.1% SDS at 72°C and were autoradiographed overnight.
DNA Preparation
DNA was prepared from positive subclones with a Wizard miniprep kit (Promega UK Ltd, Southampton, United Kingdom), according to manufacturer's instructions.
Sequencing
DNA from positive subclones was subjected to automatic sequencing on an ABI 377 Automated Sequencer by using Rhodamine or Big Dye Sequencing kits (Applera, Warrington, Cheshire, United Kingdom), in accordance with the manufacturer's instructions.
Primer Design
Sequence tagged site (STS) primers were designed from repeat-free regions of sequence (repetitive sequences were screened out by using Repeat Masker [http://repeatmasker.genome. washington.edu/cgi-bin/RM2_req.pl]) by using the primer design program Primer 3 (http://www.genome.wi.mit.edu/genome_ software/other/primer3.html).
Polymerase Chain Reaction
Polymerase chain reactions were performed in a total volume of 25 L, which included the following reagents: 2.5 L of 10ϫ polymerase chain reaction (PCR) buffer (Applera); 1.5 L of 25 mM MgCl 2 (Cetus); .5 L of 100 mM dGTP, dTTP, dATP, and dCTP (Applera, Warrington, Cheshire, UK); .2 L of Taq polymerase (Cetus); and 1 L of 20 mM (or 150 ng/L) forward and reverse primers.
Microsatellite Genotyping
Microsatellite markers were amplified by PCR from 10 -50 ng of genomic DNA and sized with an ABI3700 automated sequencer.
Single-nucleotide Polymorphism Identification
PCR primers were designed from sequence-flanking exons or predicted exons. Primers were used to amplify DNA from members of the four linked families. PCR products were checked on 2% agarose gel stained with ethidium bromide. PCR products were sequenced with the ABI Big Dye v3 kit, according to the manufacturer's instructions. The sequences were aligned by using the PhredPhrap program displayed with Consed (http:// bozeman.mbt.washington.edu/index.html). The new single-nucleotide polymorphisms (SNPs) discovered in this way have been submitted to dbSNP (http://www.ncbi.nlm.nih.gov/projects/SNP/ index.html).
Linkage Analysis
Two-point parametric linkage analyses were performed by using the program MLINK from the LINKAGE package (Terwilliger and Ott 1994) for F22 and F59. Within each family, microsatellite markers were genotyped on those family members that were necessary to determine both the linked haplotype segregating in each family and to identify any recombination breakpoints (this was at least 25% of family members). Twenty-four markers were genotyped on F22, and 57, on F59. PedCheck (O'Connell et al 1998) was used to check for genotype inconsistencies. The models used are as described in Blackwood et al (1996) ; that is, narrow definition of phenotype (model 1) bipolar 1 and bipolar 2 disorder and broad definition of phenotype (model 2) bipolar 1 disorder, bipolar 2 disorder, and recurrent unipolar disorder. Cases with other psychiatric diagnoses were coded as unknown. Age-dependent penetrances were applied to controls. Given the structure of the families studied, only a dominant mode of inheritance was considered. Disease-allele frequencies, age-dependent penetrances, and phenocopy rates for the narrow-and broad-analysis models are as for model 1 and model 2 in Blackwood et al (1996) . Equal allele frequencies were assumed, and modification of these did not have a significant effect on the results (data not shown).
Allele-sharing Analysis
The genotypes of 46 individuals from the four families were reconstructed into chromosomes by using the Merlin software (Abecasis et al 2002) . Although allocation of specific alleles to haplotypes was generally possible, some ambiguity remained: 83 markers of 284 retained a degree of ambiguity, but on average, only 7.35% of the chromosomes in question were ambiguous. Within each family, the single haplotype that was shared by all affected individuals contributing to the linkage was denoted the linked haplotype for that family. There were 38 other chromosomes in region B and 37 in region D, which were designated control haplotypes. For F22 and F59, model 1, that is, bipolar 1 and bipolar 2 disorder, was used when determining the linked haplotype. This was expanded to include schizophrenia and schizoaffective disorder for F48 and F50. There were no individuals in these diagnostic categories who did not carry the linked haplotype. Further details on the families are provided in Table 1 .
Pairwise comparisons were performed between all pairs of haplotypes within the linked group and separately for all pairs within the control group. For each pair of haplotypes, each marker was assigned a score on the basis of the size of the region of allele sharing in which it was found (based on the methods of 
The table lists the number of generations and, for each generation, the number of affected (broad category) or unknown and unaffected individuals, with the number genotyped in parenthesis. The number of unaffected and unknown individuals with the linked haplotype is shown in square brackets.
Van der Meulen and te Meerman [1997] and Bourgain et al [2000] ). Briefly, if an allele of a marker was shared between two haplotypes, then the number of alleles shared at adjacent consecutive markers determined the score for that marker (e.g., if alleles at three consecutive markers were shared, then each marker received a score of three). Scores at markers with ambiguous genotypes were weighted on the basis of the ambiguity (e.g., if it was known that a chromosome could carry one of two alleles at a particular marker, then that marker would contribute a score of .5). The scores were averaged across the pairwise tests to generate a length statistic for each marker for both the linked and control haplotypes. This then allowed definition of the extent of allele sharing between the linked haplotypes and between the control haplotypes.
Permutation Testing
Because it has been shown that the distributional properties of the length statistic are complex (Tzeng et al 2003) , we used permutation analysis to test the null hypothesis, that is, that no difference was observed when the level of sharing among the linked haplotypes was compared with that among the control haplotypes. For the permutation analysis, all linked and control haplotypes were randomized and reallocated to the linked and control groups while retaining the proportion of haplotypes allocated to each group. The allele sharing analysis was then repeated with these redefined haplotypes. This process was performed 9999 times. The p value for the length statistic at each marker was calculated as p ϭ s/10,000, where s was the number of times that the length statistic for the permutation replicates exceeded the length statistic using the real linked haplotypes. Statistical significance was investigated when p Ͻ .05. Where there was more than one consecutive marker with p Ͻ .05, the average p value and the number of linkage disequilibrium (LD) blocks were calculated for the region.
Many markers have been tested, and so some correction for multiple testing is required. Linkage disequilibrium between markers means that a Bonferroni correction would be overly conservative. Therefore the permutation replicates were used to account for multiple testing. Each of the 9999 permutated replicates was tested against all other sets of permutations in an approximation of a set of nested permutations (Becker and Knapp 2004) . A p value for each marker was generated for each of the permuted replicates, as for the linked haplotypes described above. A corrected p value then was calculated from r/10,000, where r was the number of times that a permutation replicate covered as many LD blocks as the region found in the linked haplotypes and at a greater level of significance.
Investigation of Shared SNPs
To investigate the effect of nonsynonymous SNPs, we submitted multiple protein sequence alignments to the sorting intolerant from tolerant (SIFT) algorithm website (http://blocks. fhcrc.org/sift/SIFT.html), which uses a conservation-based approach to estimate the probability that a particular amino-acid change will be tolerated by the protein. Only predictions with enough sequence information to be meaningful (median sequence information of Ͻ3.25) were considered.
Accession Numbers
The following were the accession numbers used. For Genbank, BV677285 to BV677322; for dbSNP, ss46563120 to ss46563185.
Results

Markers for Linkage and Haplotype Analysis
Initially, we performed linkage and haplotype analysis with publicly available microsatellite markers. Once these were exhausted, we identified additional markers. At first, these were identified experimentally, by subcloning PAC and BAC clones from our contig across the majority of the linked region (Evans et al 2001) . However, as more genomic sequence from clones in the region became available, we moved to in silico identification. In total, the two approaches resulted in the creation of 44 microsatellite markers. Where the supply of potential microsatellite markers had been exhausted, STSs were designed around publicly available SNPs which were amplified and sequenced in key family members, testing the informativeness of the polymorphism in those individuals.
Reevaluation of F22 Members
As expected, since the initial report of F22 (Blackwood et al 1996) , there have been changes to the clinical status of several family members. Although we have been unable to follow up all family members, we have identified five new cases: one of BPAD and four of recurrent unipolar depression. These include one individual who was previously unaffected, two who previously had minor psychiatric illness, and two who were identified and assessed subsequent to our original report. In addition, the five offspring in one family were removed from the analysis because major psychiatric illness was present in first-degree relatives of both parents. This updated phenotype information was used in the linkage and haplotype analysis described in the next section. Details of F22 and the other families studied are given in Table 1 .
Linkage and Haplotype Analysis
We genotyped the polymorphic markers in key individuals from the four linked families and determined the haplotypes linked to disease susceptibility (the linked haplotypes). In F22, four of the five newly diagnosed individuals carry the linked haplotype. One individual with a diagnosis of unipolar depression did not carry the linked haplotype and appears to be a phenocopy. Two-point parametric linkage analysis on the updated F22 data produced a maximum LOD score of 4.41 at marker D4S394, under the narrow diagnostic model (previously 4.09). LOD scores were also calculated for F59, because this had not been performed previously. The highest LOD score was obtained for F59 at D4S431 (.88 for the broad model, four affected individuals with genotype data available). This LOD score, although small, contributes to the growing evidence for a predisposition locus in this chromosomal region.
Haplotypes were constructed for all four families. Figure 1 shows the overlapping linked haplotypes that determine the position of the candidate intervals and allow us to prioritize subregions. The boundaries of the candidate region are defined by the 20Mb linked haplotype in F22 and divide into four subregions as defined by the boundaries of the linked haplotypes in the other families (Figure 1, regions A to D) . These genomic regions can be prioritized for further analysis by the strength of linkage evidence provided by the different families. On this basis, D (4.4 Mb) appears to be the best candidate region, followed by B, C, and A. However, region B (3.8 Mb) is also attractive for prioritizing for further study, because it is implicated in the three Celtic families, which potentially share a common ancestral origin.
Detection of SNPs for Allele-sharing Analysis
SNPs were identified by amplifying and sequencing exons, exon-intron boundaries, and the region approximately 1 kb upand downstream of the 20 known genes (see Table 2 ) from intervals B and D using DNA from family members. We defined Figure 2 . Allele sharing, measured by the number of consecutively shared markers, between chromosomes linked to psychiatric illness (linked chromosomes) and control chromosomes for region B. The allele sharing between linked chromosomes is represented by crosses, and between the control chromosomes, by circles. The position of the markers is given in Mb along the chromosome. There is one area of increased allele sharing between the linked chromosomes in region B. known genes as those genes with RefSeq status codes predicted, provisional, reviewed or validated and that had a protein described in Swissprot. We chose to sequence PCR products amplified from family members, rather than relying on publicly available SNPs, because this would result in the identification of SNPs specific to the populations under study and confirm the existence of database SNPs in our population. We identified 68 novel SNPs and characterized 216 publicly available SNPs in this sample (described in SOM Table 1 ).
Analysis of Allele and Haplotype Sharing
Three of the four families show linkage to region B and three to region D (Figure 1) . In each region, this led to the identification of three haplotypes (one from each linked family) that were linked with the disease and 38 control haplotypes in region B and 37 in region D. In both regions, allele sharing between the three linked haplotypes was compared with that between the control haplotypes by counting the number of markers that make up a region of sharing. Within each group of haplotypes (linked or control), there may be an artificially high level of sharing where multiple markers have been genotyped within single LD blocks. However, the comparison between the linked haplotype and control haplotype sharing will adjust for this. The significance of the difference in sharing between linked and control haplotypes was assessed by permutation analysis.
For example, in region B, a haplotype consisting of 48 consecutive markers over five LD blocks (covering ϳ200 kb)
showed excess allele sharing (Figure 2 ) between the three linked haplotypes (from F22, F59, and F50) when compared with the control haplotypes. To assess the significance of this result, we permutated the 38 control and the 3 linked haplotypes, randomly assigning chromosomes to either the linked or control group, and then calculated how often we would expect to see this result by chance. This indicated that the excess sharing in this subregion was significant (p ϭ .007; Figure 3 ). Six other subregions also showed excess sharing (Figure 2 , region B and Figure 4 , region D). These are listed in Table 3 . Three of them also are marginally significant after the permutation testing ( Figure 3 , region B; Figure 5 , region D; and column 6 of Table 3 ). We then corrected for multiple testing by examining how often the permuted chromosomes generated an equivalent or greater significance. We did this by approximating nested permutations for each permutated set of chromosomes. For example, for the region described above (shared region 1 on Table 3 ), sharing across this number of LD blocks and with this level of significance was found in only a small percentage of permuted chromosome sets, leading to a corrected p value of .009. This was the only shared region that remained significant after correction for multiple testing (Table 3 , column 7).
Investigation of Shared SNPs
We examined the 48 SNPs in the significant shared region (National Center for Biotechnology Information build 35 May 2004 assembly coordinates: 9,576,583-9,777,081; Table 4 ). Thir- ty-three of the SNPs are in SLC2A9, a member of the facilitative glucose transporter family. Twenty-eight are intronic and five, exonic. None of the intronic SNPs lie within known consensus splice sites. To investigate the possible functional consequences of the nonsynonymous exonic SNPs, we used the SIFT algorithm (Ng and Henikoff 2001) , which uses multiple sequence alignments to predict tolerated amino acid substitutions. Only the R294H variant was predicted to affect protein structure or function (p Ͻ .04). Two SNPs are intergenic, and the remaining thirteen are in WDR1, a WD repeat domain protein.
Ten of the WDR1 SNPs are in introns and three in exons. None of the intronic SNPs lie within known splice consensus sequences. The three exonic SNPs all are found in the 3=-UTR region. Because all of the shared SNPs were also present on at least 30% of control chromosomes, it is unlikely that any of them are the sole functional variant in this region. Instead, it is more likely that we have identified a shared haplotype that carries the functional SNPs.
Discussion
The additional cases of major affective disorder in family 22 described in this 10-year follow-up have confirmed and strengthened the linkage result to this region of chromosome 4p. This study demonstrates the value of large families when analyzing complex conditions such as BPAD, where in many cases there is phenotypic complexity and almost certainly locus heterogeneity and oligo or polygenicity. Like other complex disorders including breast cancer [MIM 114480 (Potash and DePaulo 2000) .
We have generated new microsatellite and SNP markers and used these in genetic analysis of families with chromosome 4p linked BPAD and other, related phenotypes. The high-resolution haplotype analysis described allows comparison of the F22 linkage region with the linked haplotypes in other families. Although F48 also generates a LOD score of Ͼ3, the inclusion of families that have the capacity only to generate smaller LOD scores is a higher risk strategy, because of the increased likelihood of false positives. However, because these families contained affected individuals with recombination events that were complementary to those of the larger families, this allowed us to prioritize subregions of a large candidate region (Figure 1 ). On the basis of this linkage evidence, we then attempted to bridge the gap between the resolution provided by linkage analysis and that of association studies by assessing allele sharing in known genes from regions B and D. Our allele sharing method combined a modified version of a measure of allele sharing described elsewhere with two rounds of permutation analysis (Van der Meulen and te Meerman 1997; Bourgain et al 2000) . The first assesses the significance of the finding, and the second accounts for multiple testing. As far as we are aware, these three aspects of the method have not previously been combined in this way with this aim. Data include the properties of the regions of excess sharing, the subregion of the F22 linkage region to which they map, the number of shared markers within them, the number of linkage disequilibrium (LD) blocks they cover, their length, the p value after the test for significance, and the p value corrected for multiple testing. homeostasis. An imbalance in glucose homeostasis leading to, for example, altered energy provision to neurons could be invoked as a predisposing mechanism to psychiatric illness. A putative link between energy provision and bipolar disorder has already been made; there are a number of lines of evidence implicating mitochondrial dysfunction in bipolar disorder (Kato and Kato 2000) . WDR1 encodes a brain expressed protein containing nine WD repeat domains that provide proteinprotein interactions thought to induce the disassembly of actin filaments, offering a plausible mechanism for neuronal dysfunction.
No excess allele sharing was identified in genes from region D. This is not unexpected because, in contrast to the case in region B, the families are from ethnically diverse populations.
In conclusion, definition of the linked haplotypes and analysis of the extent of allele sharing between families has allowed us to highlight positional candidate genes and subregions of the chromosome 4p BPAD candidate region that are worthy of intense study.
